Med-Chemist

Med-Chemist : "Quintessential Medicinal Chemistry"

Showing posts with label Nintedanib. Show all posts
Showing posts with label Nintedanib. Show all posts
Monday, July 13, 2015

Nintedanib in lung cancer: Added benefit depends on disease severity

›
In continuation of my update on Nintedanib According to the findings, there is an indication of a minor added benefit of nintedanib ...
Wednesday, November 20, 2013

Nintedanib drug to treat NSCLC is submitted for approval from European Medicines Agency

›
In continuation of my update on NSCLC (non-small cell lung carcinoma) We know that,  Nintedanib  (see structure, formerly  BIBF 1120 ...
›
Home
View web version

Contributors

  • Dr. Umesh..
  • https://www.med-chemist.com
Powered by Blogger.